Company Overview
Snapshot
Founded in May 2021 by Oded Melamed, Dan Charash, Prof. Barak Dayan, and Gil Semo, Quantum Source operates with 51–200 employees. The company has raised $77 million across 3 funding rounds from 8 investors. In September 2024, Quantum Source secured an A Round of funding, with Eclipse Ventures and Standard Investments participating.
Business overview
Quantum Source Labs is developing photonic technology to scale quantum computers to millions of qubits. The company's core product focuses on large-scale photonic quantum computing, aiming to revolutionize industries such as pharmaceuticals by accelerating drug development and optimizing treatment for complex diseases. Quantum Source operates within the Industrial Technologies sector, specifically targeting the Healthcare & Life Sciences market, with a focus on Pharmaceuticals.
Strategic signal
In September 2024, Quantum Source secured a significant A Round of funding, with Eclipse Ventures leading the investment. This capital infusion signals strong investor confidence in the company's photonic quantum computing technology and its potential to scale quantum solutions, reinforcing its trajectory as a key player in the advanced computing landscape.
Company Intelligence Q&A
- What was a key development for Quantum Source in September 2024?
- In September 2024, Quantum Source secured an A Round of funding, with Eclipse Ventures and Standard Investments participating.
- When did Quantum Source extend its Seed round?
- In April 2023, Quantum Source extended its Seed round, with Dell Technologies Capital leading the investment and Grove Ventures also participating.
- When was Naftali Bennett appointed to the board of directors?
- Naftali Bennett was appointed to Quantum Source's board of directors in May 2023.
- What was the initial Seed funding for Quantum Source?
- In July 2022, Quantum Source raised Seed funding, with.
- What is Quantum Source's primary focus?
- Quantum Source is focused on using its photonic technology to enable the scaling of quantum computers to millions of qubits, aiming to revolutionize industries like pharmaceuticals.